I am at a loss both mentally and financially about the goings on here.

The company is involved in health care and all it's peers have risen substantially.

Debt has been cleared, profits are rising and the chairman's statement was incredibly positive. I always thought a star of this kind would rise. Low market value etc etc. Any ideas why I'm apparently wrong?

JRM, you started a thread on the share only a few days ago. I know at the end of the day it's up to you if you want to start a new thread - and I don't have the right to tell you what to do etc. etc. etc.

But I have a question - is there a reason you didn't continue the first thread you started?

Agreed lw - just noticed the same thing on ASM. Let's stick to 1 thread please.

I thought the lack of interest in the third thread was possibly caused by the failure to include the company's name in the message

Most people who have been trading for a while go by the EPIC rather than title. You just have to persevere, and keep posting on the thread and hope that others will eventually join in.

I often will take a look at a thread thats been going a while which I have not previously had any interest just to read the history and see if its worth maybe taking a look. I don't know what make others look at threads other than a direct interest in that company

Thankyou

Sorry about the quick post previous JRM but new to the MoneyAm boards and still finding my feet. However Iam a Surgical holder 250k and my aim is for the longer term.Another fall today which has become the norm for Sun over the last few years but I do feel that next year we will all see the share price moving forward.I think most will agree that the company has great products and maintained a small profit for several years even with spending a large amount of income on development.This should change now with revenues from the successfull launch of the Variglide product and the soon to be upgraded ABT blood kits.The company has been seen taking on more staff so that must also point to coming expansion,along with the Chairmans recent upbeat outlook.Must be in with a chance to roll.Cheers Zepher

It seems to me that surgeons,both here and abroad,are slow to change and therefore it is taking much longer than expected to gain market share.The potential for growth here is significant,however,and at the first sign of sustained success,we can expect the price to move up sharply.

Thanks for the feedback, when I first bought the shares a Doctor shared these same concerns with me. The company seems so quiet. I hope they're more noticeable in the market place!

Ticked back up thisafternoon,last buy was 286,000 price 2.62p at least someone has spotted an opportunity.

I'm glad a small number of us still believe!

Yes JRM Iam here for one,looking to gain a few more in the not to distant future.

There is certainly some potential here!

It's a little quiet at the moment!

Quietness breeds content,happy to wait for this to move next year.

Next year!

I agree with the sentiment that this is a longer haul play and you should really tuck the shares away.There was a BBC news report which summed up the slow pace at which the NHS is absorbing new government money for technology change---the first tranche of money has gone in higher wages and additional staff---only now are they starting to look at new equipment.

Useful thought!

I'm an expert at tucking this shares away.I have held 100,000 @2.74p since 1999!! .Do nudge me when this company decides to wake up!!! But please don't hold your breath,even with the low interest rates you'll make more by tucking your money away in a bank!

I'am no expert in this share but I do hold 200,000@1.94 bought previous to when the company was tipped by the Sunday Express at 2p.The paper was referring to a recent contract it had secured valued over 2m and an excellent line of products for the future,stating in its opinion the company was undervalued.
Many including myself have been frustrated that the expectation at that time has yet to be realized but with the new revenues about to kick in from the Variglide and a partnership to develope the ABT product I'am more than happy to hold.Cheers Zepher.

There seems far more interest here than with poor old Swan Hill!

Slipping I surpose!

At this price its got to be a better bargain than the Xmas Sales,roll on the New Year.Cheers Zepher.

Slumbering peacefully out of the old year,what delights await us all in 2004.A happy and prosperous New Year to all.
Cheers Zepher.

Wake up message from Yahoo Finance. Sun Technical Analysis Medium Term Commentary.Be alert to the aproximity of Support 2 and possible rebound from this level.Daily and weekly technical indicators alert of the proximity of a market bottom.Keep track of possable bullish divergences on RSI that will confirm this scenario.

I hope they rise too, having a few shares here.......

Surgical Innovations plc 2.25 bid(SUN)is one of our 2004 selections for 2004.To view article go to WWW.Lemmings Investor.Com and click on company focus for January.

Recorrect above to read WWW.LEMMINGINVESTOR.COM
Cheers Zepher.

Somebody awake today, traded 500,000k at 2-50p.

Does anybody know the reason for the large number of sells that have gone through over the past weeks, this company looks very decent to me. By the way, does anyone know when the results are due, they should be good.

Results due March no date mentioned see SIgroupPLC.com
Last chairmans statement reported that talks with their partners regarding the marketing of their Variglide system should be completed around this time.
Westward TV also had interesting item on Obesity,which the chairman also mentioned an opportunity for the companys products.An operation for patients with severe obesity has been a huge success over 2,000 ops to complete,however the NHS has said it has no chance of coping with demand,the TV report added that a boom was about to happen in private hospitals for the treatment.The operation carried out by keyhole surgery takes around 40mins,not sure where Sun may be able to fit here but with Obesity now target No1 in health matters around the world it could return useful revenues for the company.

IS IT WORTH BUYING MORE AHEAD OF THE RESULTS?

Nice buy at 14-41 today 400k at 3p,buyer may have the answer?

How do I view earlier entries?

More blue today!

Come on!

Another 400k at 3p but no blue, never mind keeping the faith.

A slight slip but the results are coming

Down 9% today but those results will cheer,last chance to climb aboard?

I hope!

Another Friday and another 400k buy,any bets on next Friday making it four in a row(not me by the way)but someone is confident.

Hello "zepher", What are your thoughts on SUN at this stage. Would like to know. Rgds. jnk

jnk
Keeping my stake in Sun as I feel that patience will eventually be rewarded in this share.The opinion of many in their field of health products agree that they have an excellent line of products,if they are right then we may see more profit and future growth with a healthy share price.Looking forward to the results and more upbeat news this coming year,up 10% this morning just maybe?

It's an encouraging start!

Lets hope that Sun will shine for us as market clouds are gathering.

Yep!

when will they be releasing the results? as anyone heard how good or bad they are going to be?

windys160 the results are due soon around end of March,all speculation has revolved around the comments of the chairmans last report when he forcasted a very upbeat second half performance for the company.In truth we should all hope that he is correct as little news is available from the company,however it is known that the Variglide system has been launched with the 300m US market on the horizon, early sales may have boosted turnover and added to Sun previous small profit,lets all hope this is the momment when Sun starts delivering.

Yep!

Thursday 29th April 2004 not D day but an important one for Sun and all shareholders,will those results match the chairmans statement,at least the speculation will be over and we can make our minds up about the future prospects for the company.

That's a while!

Ive made my mind up,hoping for some confirmation on the 29th, hope its a +

That's encouraging I need a riser!

That's encouraging I need a riser!

Our Friday buyer in again this afternoon 400k @2.75 check previous page must be nearing 50k over last month.

It's nice to know that somebody really believes!

Belief is eternal Sun is pleased to announce it has entered into a cross-licencing agreement with leading US medical device manufactuer Applied Medical Resources.

Above must be worth more than 0.25 rise never mind perhaps they are still on hols or coming around from shock,anyway more interest in this share must be forthcoming soon!

The FT,Independent and Express all thought it worth a write up today,a little ray of sunshine on a gloomy looking day for the markets.

Results out at the end of the month.
Last years statemements very positive.
Further link ups possible.

Looking good.

I can't wait!

Results next week will a Sunday paper pick -up on this or will Friday's buyer go mad this afternoon?

JRM looks like somebody dipped in for a few,watch out for the Express they have tipped Sun previously at 2p saying they were undervalued,wonder where the company is at the moment,looking forward also to more news of the US deal.

Somebody will hopefully know something good!

Two days left!

The buyers are coming!
1 day to the results!

Record profits
Record order book and optimism!

Will anybody buy the shares today?

Any thoughts?

A slow start but the buyers are now coming!

Come-up!

Why is nothing happening?

Have I missed something?

Patience my son patience - all the short term punters are gone nows the time
to buy in.....

About time I was ready to go home!!!!!!!!!!

Looking really good now,very few looking to bank their profit at present as it looks like 10p+ could be in the offering with further good news soon,excellent prospect.
Z.

I'm assuming the results at the end of the month are crackers and the cats out of the bag. I've held these since 2002 and every year the results have improved, has anyone heard anything?

Heard nothing Ryce, but have held for a while, been slowly buying more. SUN, to my mind, has been off radar for far too long; as you say the results improve each year and the last 12 months look to have taken the company to new heights. I am expecting the biggest improvement yet in the latest accounts, with probably more good news thrown in. I have not been able to find anything detrimental about SUN and look forward to a measured improvement in the SP over the next 12 months, or sooner.

Thanks Kim

Massive potential in this one boys - been a holder for years & years since heamocell - worth the wait.

Could soon go to 9p

Final Results

We have today announced our final results for the twelve months ended 31 December 2006.

Highlights
Eighth successive year of record sales, profit and earnings per share
Pre-tax profits increased substantially, up 98% to 696,000 (2005: 352,000)
Revenue up by 11% to 4.46 million (2005: 4.02 million)
Basic earnings per share (EPS) increased by 69% to 0.27p (2005: 0.16p)
Significant growth in sales of Minimally Invasive Surgery devices (up by 36%)
US sales focus aided by additional patent clearance and FDA approval
R&D expenditure increased by 18% to 292,000 (2005: 248,000), representing a significant investment in the Groups future product range
Simplification strategy implemented, improving production efficiencies for 2007 and beyond
Significant contracts already signed in 2007 with Teleflex Medical and Elemental Healthcare

Commenting on the outlook, Doug Liversidge, Non-executive Chairman, said: After our eighth successive year of record performance, we approach 2007 and beyond with both enthusiasm and excitement. Fuelled by an ever-strengthening innovation and intellectual property base, combined with significant new distribution agreements, the Group looks forward to achieving further improvements in operating margins and continued business growth.

CHAIRMANS STATEMENT

Introduction

I am delighted to be able to report another year of excellent progress for Surgical Innovations Group Plc (the Group). For the eighth successive year the Group achieved a record level of sales, profit and earnings per share (EPS).

The Groups reported sales revenue grew by 11% to 4.46m (2005: 4.02m). Significantly, sales within our core business of Minimally Invasive Surgery (MIS) devices rose by 36%. This has encouraged your Board to invest additional resources in potentially lucrative internal development projects for new surgical devices.

Importantly, we have been able to deliver an improvement in our MIS operating margins as a result of our focus on manufacturing processes relating to our strategic product lines.

The Board has taken the view to capitalise 190,000, of research and development costs, net of specific grants, as they fulfil the requirements of the relevant accounting standards.

As a result, pre-tax profits have increased by 98% to 696,000 (2005: 352,000) which translates into basic EPS growth of 69% to 0.27p (2005: 0.16p).

Business Review

Instrument Division revenue increased by 36% to 3.65m (2005: 2.68m). This performance is testament to our key product lines; the YelloPort port access system and the Logic single use scissors range. We are currently focusing our efforts on the United States laparoscopic market and substantial work has been undertaken during the year to establish clear routes to market.

Product Development Division revenue totalled 313,000 (2005: 535,000). This income was generated from clients in both the medical device and industrial sectors. New customers were secured building upon our success with Rolls-Royce in 2005. This type of work from external customers can be extremely profitable, although it remains unpredictable, usually driven by urgent customer needs. Therefore, we took the decision to invest heavily in the year in internal MIS product development. Our aim is to build upon our international network of MIS distributors, with its high demand and enthusiasm for new innovative products.

Royalties from the licensing of EndoFlex to Cardinal Health totalled 249,000, a decrease of 11% on last year (2005: 281,000). After allowing for adverse currency exchange rates during 2006, the actual sales value of our licensed products fell by only 2%. We worked closely with Cardinal Health during the year to develop an international presence for EndoFlex, utilising our established distribution partners with a view to sustaining future royalty income. In addition, we continue to receive a licence fee from Rolls Royce whilst exploring arrangements for future licence fees and development work from other industrial companies where our technology may have possible applications.

Our Autologous Blood business was adversely affected during the year by changes to our external manufacturing arrangements. I am pleased to report that we have now resolved these issues and we are actively seeking partners to develop a coherent strategy for both our intra operative and post operative product lines.

Overall the Group has enjoyed a successful year, laying a further platform for growth in profitability and new product development.

Product Development

2006 saw a renewed focus on the development of devices to complement our existing MIS product portfolio. During the year our expenditure on research and development, before government grants of 46,000, increased by 18% to 292,000 (2005: 248,000), representing 6.5% of sales (2005: 6.2%).

The creation of intellectual property is a key element of our investment in product development. I am delighted that we successfully filed patents on technology intrinsic to one of our products positioned for launch in 2007. Our current patent portfolio has enabled us to generate over 2.7m in royalties and licence fees. It is our intention to aggressively grow and defend our intellectual property portfolio.

Board of Directors

Our Group Board has worked diligently as a team during the year and, importantly, the level of support provided by the Non-executives to the Executive Directors continues to develop in line with the growth of the business. The Operations Board is now well established and has significant levels of expertise in all areas of operation of the business.

Employees
The Group is committed to the development and retention of its high calibre staff, which we believe is the key to achieving the Groups ambitious growth plans. I am delighted to report that we have recently recruited an experienced clinical specialist to oversee forthcoming product launches in the United States and our other overseas markets.

I would like to take this opportunity to thank all staff for their dedication and support during the year in which we again continued to provide high quality innovative devices to the surgical profession.

Outlook
Our immediate plans focus on the launch of our products developed during 2006. The United States is a key market for us and with US Food and Drug Administration (FDA) approval now received, together with patent clearance, we are well placed to establish a presence in this dynamic and growing market.

Although I have to report that Aesculap has decided not to renew its OEM scissors contract with us, such a situation is always a possibility with this type of business and plans are in hand to mitigate the effects. We recently signed a 1.15m three year extension to our contract with Teleflex Medical for distribution of our products in Europe. Furthermore, as part of a review of our distribution arrangements, we have appointed Elemental Healthcare, through a 1.74m four year contract, as our distributor in the UK. Negotiations are also underway with regard to establishing a master dealer for all our business in the Far East and Indian sub continent, where we believe there is a major opportunity for our products.
We approach 2007 and beyond with both enthusiasm and excitement. We look forward to achieving further improvements in our operating margins and the continuation of growth in the business.

Doug Liversidge CBE
Non-executive Chairman
April 2007


DATE: 30/04/2007




Although it is a little disappointing that Aesculap has decided not to renew its OEM scissors contract, SUN says 'such a situation is always a possibility with this type of business and plans are in hand to mitigate the effects': I am confident that this will not cause any problems for the company and will continue to buy when the opportunity arises. But as always, DYOR.

Non-executive chairman Doug Liversidge said SUN 'looks forward to achieving further improvements in operating margins and continued business growth'.

Although SUN is still a minnow, it is very much swimming in the right direction

anyone following this?

Yep
Tipped again in todays Shares mag,should see a new climb in the sp after the volitility of the recent share placing,real growth prospects are the feature for todays tip by Shares.
Z.

i think June July we should see some movement

Zepher- do you think you can pose the whole article please if possible??

MACD about to cross over and MA RSI is oversold we should see the SP move NORTH - IMO

Surgical innovates in the US

View Gallery
By Eric Barkas City Editor
Medical devices company Surgical Innovations is raising 4m before expenses via a share placing so it can develop its businesses.

Of the net sum raised, about 1.25m will be used as working capital for the Leeds-based company's US operations.

In December Surgical announced it had made inroads into the US market with an agreement to supply its YelloPort abdominal access system to one of America's biggest hospital groups.

Surgical is best known for devices used in laparoscopic surgery - a less invasive, keyhole, technique than conventional surgery. It produces the instruments and the access ports through which they are introduced into the body.

The company said yesterday that in the US, where 1.5m general laparoscopic surgery cases were performed last year, it had established relationships with major suppliers who would incorporate YelloPort in their customer offer.

Another 1.8m of the placing money will be used in the sales channels to deliver Surgical products to North American and European markets. That means developing existing product licences and winning new licences in markets where purchasing procedures are varied and differing marketing strategies are required.

Some 750,000 is earmarked for product development.

Surgical says its products have been well received South Africa as well as the US. Patents have been filed on the technology that is the basis for one new product.

Further funding is said to be needed for products as well as putting the necessary manufacturing capability in place.

yes but i dont agree with lining the pockets of the directors and advisors - whats wrong with an open offer to all shareholders including ones like me who has seen it all over the last 15 years!!!!!!!!!!!!!!!!!!

True..

On way back up?
Should be...considering
New business with GE Inspection Technologies for the inspection of large frame gas turbines.
Development contract with Gyrus ACMI for the design of a novel,handheld instrument now looking at upcoming commercialisation shortly.
and
Yelloport successful in supplying to the US Air Force base in North East Italy with possibilities of business with other worldwide US military bases.

Looking Good MA MACD crossing and crossed over.. RSI is oversold ...

IMO we should be moving North

LOOKING EVEN BETTER NOW !!!

Nar1, yess v good news & hopefully a climb in the 4th quarter of the year. on the watch list !

Nice bit of news on a day when the sun actually is shining in North Wales!

US Distribution Agreement



Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of
innovative surgical devices, announces that it has signed a distribution
agreement with MGM Med Inc. ('MGM'), a wholesale distributor of medical and
hospital equipment, for the provision of its laparoscopic equipment to the US
market.



Under the terms of the agreement, MGM has the right to use the Surgical
Innovations ('SI') name and will promote the SI brand through its newly formed
subsidiary, Surgical Innovations US Inc. ('Surgical US').



Surgical US will become the master distributor of SI branded products in the US
and will engage with new key channel partners including surgical procedural tray
companies, major medical distributors and small independent representatives that
service more than 6,000 hospitals in the US market



The agreement incorporates a minimum sales target of US$20 million, net to SI,
over the five year term.



The agreement has already led to the appointment by Surgical US of its first
channel partner, Tri-anim Health Services, Inc. ('Tri-anim'), a leading
specialty distributor of medical and hospital equipment in the US. Tri-anim
will begin sales of SI's single use laparoscopic scissors from August 2007,
initially in the south east of the US and increasing thereafter on a regional
basis, eventually providing nationwide coverage.

Mary Meyer, President and CEO of Surgical US, said: 'The US market for single
use scissors is currently valued at over US$125 million and we see huge
potential for SI products throughout the entire US laparoscopic equipment
market.'



Graham Bowland, Finance Director of Surgical Innovations Group plc, commented:
'The creation by MGM of Surgical US provides new and exciting routes to market
for SI's products, further expanding our presence within North America. The use
of the Surgical Innovations trademark will increase our brand recognition across
the US and will support our strategy for future growth.'

MACD - crossed over and some very good news !!

but needs the market to stay positive for a while otherwise the sp is likely to drop back

did market stay positive then ?? Still don't know what to do with Surgical shares...

Down at the moment ..... time to top up if you want ??

Hello. Anyone got any news on the upcoming interims? I haven't been able to find out how the new USA deal is going

Article in Yorkshire Post

"RESPOSABLE" is one of the words on the lips of Surgical Innovations finance director Graham Bowland. It's how the surgical devices company describes instruments that mix both re-usable and disposable components.
Leeds-based Surgical says such devices are proving to be more cost-effective than their fully disposable counterparts and, by focusing on them, the company is gaining a competitive edge.

Trademark is the other word Mr Bowland is keen to emphasise as Surgical seeks to both patent its devices and register them. The devices are for laparoscopic keyhole surgery.

The company is focusing more on developing, making and selling its own branded products.

Losing a big contract with Aesculap for surgical scissors showed the importance of the company's own brand compared with work for other manufacturers.

So, Surgical decided to invest more on designing its own products and was less concerned in design work for others. The upshot in half-year figures out yesterday was a fall in revenue to 1.9m from 2.1m and in pre-tax profit to 118,000 from 182,000.

Chairman Doug Liversidge says revenue lost with Aesculap is being replaced at a better margin by own-branded products, adding: "I'm now very comfortable with the position of the business."

Not that Surgical has given up its work for other manufacturers. Indeed, it has restructured itself into three trading companies, one of which, Core Precision, is dedicated to surgical and industrial solutions for such manufacturers.

The company has for some time been working with Rolls-Royce to supply "keyhole" devices to repair aero engines without the need to take the engines apart. It is also working with GE on devices to repair gas turbines and with Gyrus on gynaecology instruments.

In the blood business Haemocell, which enables patients to give their own blood rather than risk infection from donors, Surgical is looking for an international partner.

The biggest demand for Haemocell technology is from regions like the Far East, Middle East and from Russia, Mr Bowland says, so it makes sense to go into partnership.

The group structure should provide more focus for the individual businesses, Mr Liversidge says.

The core Surgical Innovations business has seen a lot of action lately. Much work has gone into the new YelloPort + Plus resposable device. The port is the access to the body for instruments, helping guide them to their target.

The new device combines re-usable main elements and disposable accessories.

In the last nine months the company has broken into the US market. First it signed a deal to supply YelloPort to one of the largest US hospital groups, North Shore Long Island Jewish Health System. Then it agreed a distribution deal with MGM Med, giving it access to the broad market.

The company is in effect licensing its brand to MGM, which is setting up a subsidiary called Surgical Innovations US.

That was seen as crucial, since many hospitals want to buy through US dealerships.

After years of disapointments we have yet more.
I though things were looking up from a SP point of view - clearly not.
The city does not look impressed.

Transco would you hold or sell? Is it worth waiting for another news or hoping that there is going to be some next contract to pump price up???

To be honest I w=have written them off.
The city clearly have no confidence in the management and I see the SP stagnating again.
Very very disapointing.

If you have a substantial holding worth anything I would sell and leave well alone in future.

"written off" not sure about that I have faith in the company and I have been topping at lower prices. Not only to lower by breakeven but also I believe in this company long term and therefore increasing my holding.

DYOR but I think this is cheap at this price, main thing for me its making money and feel my money is safe long term this will make me a nice profit.....

Well no one else seems to agree - look at the sp it tells everything!!

well i agree with transco, but i will look at this company and news from this direction ready to be back in case of some changes,I'm sure transco would do the same:)

Nar1, invest longterm for the children !

"Pumben" i hope it wont take that long ;-: nxt few months will show a change I certain SUN has alot to show !!

Transco and Fernandesb... how long have you two been holding and what is is your aim with this share.......

Transco and Fernandesb please advise by what you mean "look at the sp it tells everything" and "well i agree with transco" agree in what ??

Thanks

Nar1

well nar1 performance of this company is just disappointed, i think everybody was expecting at lease 10p this time or more, you see 3p and that is the answer.

True... But i still believe 10p can be achived and therefore Iam waiting for at least 5.5 - 6 p at the minimum before I will be thinking of pulling out... 10p is what I am after long term I think this can be done..

DYOR

I have been in since heamocell days over 10 years ago - constant disapointment.
This will never go anywhere now!!

Hope not

Nar1, as i said earlier, put them away in a "trust" for the kids, when they reach 21 hopefully you're ba able to give them a nice surprise !!!

Pumben HAHA your a funny guy 21 I'll make them millionaires if I hold that long...

Seriously I doubt I will have to wait that long these will steadily grow and increase in value and make me a nice packet!!!

You are an optimist!!

I dont see any upside until they get more orders in or receive interest from another larger business.

Its a dead duck for now!

We will just have to wait and see hey Transco !!

Just find it hard to justify the 11.1 mil market cap here, recent interim profits of 118k, i can see there's growth prospects but when i look at the thread above here
(Uvel) you have a company worth 12 million that also has growth prospects but
has just released full year profits of 1.4 million.

Where's the value ?

this is just tragic:( I'm very happy to be so short this time...

Its a dead duck rubbish share going nowhere!!

transco, do you think someone in the future may be interested to buy this company?

Well maybe but its a long shot. Definately not worth buying on the hope of a takeover.
IMHO

This will be back up just need some positive news and this will go up but we need it quick or this will continue to wonder downwards.. Iam takin a heavy loss but I will remain confident that SUN will go up and business success will be confirmed....... its just a matter if your willing or able to wait for the news !!

As Warrent Buffet says ....
'Charlie and I let our marketable equities tell us by their operating results not by their daily or even yearly, price quotation whether our investments are succesful.The market may ignore business success for while, but eventually will confirm it'

well , the only thing i didn't understand was why they stopped to trade equipment of other brands, i know it is good to concentrate on own brand and products but I'm sure that was very important part of their profit.

I'm really not that surprised that Sun is struggling shareprice wise.

If other stocks with better fundamentals are struggling to find buyers
then i cant see why Sun should be attracting them, like i said before
it's market cap was very high for what profits it was making.

The weak dollar not helping

I like many other are hanging in there but with spreads anything up to 25%, which is tantamount to theft, it could be a long wait.

Leave it in there for the children - Someone told me thats the best way to think about it.. there be a trading update soon

Nar1, Lets hope the children don't have their own before this share decides to rise !

Forget the Warren Buffet books it better to read the "Idiots" guide to investing !

Just you wait and see SUN will come good !!

Nice 0.12 rise today !!!

Definately moving in the right direction now. maybe the wait wont be so long after all. It would be good if they could push out some positive news asap to take advance of the defensive qualities of the health care band wagon

I'm watching this one, but i agree that we will need some good news and not only once to get some more investors here. Do they have any important dates coming ???

Well they released a trading update 8-1-07 last year so it could be anytime??

Best get buying ladies and gentlemen !!

but they didn't this year, maybe they have nothing to release yet , or only bad news....

Still got time to go

I think the trading update last year was a one-off Nar1, not SUN's usual style. I won't be disappointed if we hear nothing before notification in March of Results. I think it will probably have been a fairly tough year for the company since losing the Aesculap contract but I feel they were very quick to address the situation, make some important strategic changes and get themselves more organized; a sign of strong management imo. Still confident in this company, I am hopeful of a good set of results.

We shall soon know Kimoldfield

This baby can get to 20p, if everything goes as good as planned, IMO

Given time Ahoj, given time, and there's plenty of that!

0.25 up TODAY !!!!! VERY NICE

C'mon!!

This one is a winner!!!!!!!!!!!!!!! no doubt!!

mentioned in IC as one of the top 45 aim companies which could do well this year

Just pile in and sit back results in April always a good run towards April !!

Good news in the US and this will be flying !!!!

Healthy profits rise for Surgical Innovations Group

A LEEDS medical technology firm which is literally at the cutting edge of manufacturing for the healthcare sector has reported increased profits.
Surgical Innovations Group, which designs and manufactures innovative surgical devices, says it has an optimistic view of the future as it continues to develop new products.

Sales for the year ended December 31 climbed by seven per cent to 4.77m (2006: 4.46m) resulting in an operating profit of 685,000 (2006: 735,000).

Pre-tax profits were up by five per cent to 731,000 (2006: 696,000).

During the period the business completed a successful fundraising of 4m (before expenses) to aid its expansion plans in the US and to increase its product range both through acquisition and internal development.

The group, which is listed on the Alternative Investment Market, has been reorganised into three trading companies.

Surgical Innovations Ltd specialises in minimally invasive surgery devices while Haemocell Ltd specialises in autologous blood transfusion products allowing patients to give their own blood rather than risking infection from donors.

Core Precision Ltd offers surgical and industrial solutions for original equipment manufacturer partners.

Confident

Doug Liversidge, the firm's non-executive chairman, said: "I am delighted that once again we are able to report improved levels of profit and sales.

"The domestic and overseas markets in which we operate are growing and we are confident that, with our expanding portfolio of products, we will be able to continue to generate further sales growth throughout the year.

"Our confidence in our future is such that we have just completed a relocation of the business to facilities that provide us with triple the area of floor space and the capacity by which we can capitalise on this increasing opportunity."

Surgical Innovations, which is based at Clayton Park, Clayton Wood Rise, West Park, now employs over 40 people.

It began trading in 1992 as Surgical Innovations Ltd, merging with Haemocell plc in 1998 to form the Surgical Innovations Group.

The core Surgical Innovations business has developed a portal device giving access to the body for instruments and helping to guide them to their target.

The company broke into the US market when it signed a deal to supply it to one of the largest US hospital groups.

Innovation keeps Surgical operating at the front


IT'S BEEN a busy year for Surgical Innovations but that's the way the company's finance director Graham Bowland likes it.

A move to new premises in Leeds, a 4m fundraising to aid expansion in the US and the development and protection of new products under the Surgical Innovations brand have enabled the company to post improved results.

The firm, which designs and manufactures innovative surgical devices, has also been busy seeking trademark protection and intellectual property rights on a number of its products and is keen to push the Surgical Innovations brand itself.

"We've grown our own distribution network of branded products," said Mr Bowland. "And we're taking on the resources for more and more product development.

"We have the money in the bank which we can use to do this."

Mr Bowland said a major drive for the company, which has moved from its five previous units in Leeds to a 32,000 sq ft headquarters in the city, was to push its own branded devices rather than focusing on manufacturing them for other clients.

He said many of these had been a success in 2007. And the launch of YelloPort Plus, a reusable device which helps access to the abdomen for operations, in the second half of the company's financial year has achieved sales of 640,000 to date.

In the US, Surgical Innovations has a contract to supply YelloPort, which also has disposable accessories, to one of the largest US hospital groups.

For the year to December 31, pre-tax profit was up 5% to 731,000 on turnover up 7% to 4.77m.

Operating profit was down from 735,000 to 685,000.

Mr Bowland said the move to new premises had allowed Surgical Innovations to take on new designers. The company has also launched a clinical advisory board which is made up of medical experts who are helping to bring new devices to the operating table.

The company was also reorganised into three trading companies in the 2007 financial year: minimally invasive surgery devices company Surgical Innovations; Haemocell, which focuses on autologous blood products; and CORE Precision, which looks at surgical and industrial devices for equipment manufacturers.

Doug Liversidge, non-executive chairman, said: "I am delighted that once again we are able to report improved levels of profit and sales. The domestic and overseas markets in which we operate are growing and we are confident that, with our expanding portfolio of products, we will be able to continue to generate further sales growth throughout the year.

"Our confidence in our future is such that we have just completed a relocation of the business to facilities that provide us with triple the area of floor space and the capacity by which we can capitalise on this increasing opportunity."

Nar1, what are thye planning to fill the extra floor space with, collection depot for unwanted Xmas presents ?

these shares have been treated way worse than they need to be. I have a reasonable 7 figure holiding (which isnt great at 2.25) and so sitting on a considerable loss but will just sit and wait. Any company that is gearing up and extending its production capacity threefold is going places. once the exchange rate with the $ gets back to something normal the US opreation will take off

Pumben... This is why SUN need extra space....

"The domestic and overseas markets in which we operate are growing and we are confident that, with our expanding portfolio of products, we will be able to continue to generate further sales growth throughout the year.

"Our confidence in our future is such that we have just completed a relocation of the business to facilities that provide us with triple the area of floor space and the capacity by which we can capitalise on this increasing opportunity."

"We've grown our own distribution network of branded products," said Mr Bowland. "And we're taking on the resources for more and more product development.

Revenue is increasing annually and, despite the loss of a major contract, SUN continues a forward momentum. WILL NOT light up the sky like it's namesake in the near future, but shows far more promise than, shall we say, the present Labour Government! Have reduced my holding but will increase on good news, which I am confident of. DYOR

Nar 1, for a minute there I thought you were their CEO, good luck it may be a long wait !!

Cheers .... yeah it always on the cards long termer

Spec buy in moneyweek so put a few bob on this one today, not been in before.
2517

thats two of us...

Well you picked a good day to get in

the spread on this is a joke i.e nearly 25%. No one in there right mind will jump in a crystalise a 25% loss. Only when they start shortening the bid and offer will this roll higher. Still a long term hold

stroreysj---------I bought @ 2.4p and at that time sellers were able to get 2.27p so whilst the headline spread is wide all is not what it seems, I believe with such stocks the spreads tend to be wider anyway. Who said we were 'right' in the head, ha! ha! Good luck all may be a good ride on this one.
2517

i bought at 3.4 and have held for almost a year so unlikely to run for the hills just yet. I really believe in the long term story of this company once the dollar weakens and the new production capacity is brought on line. Anticipating about 7.5 - 9p after next yeras results. Long term hold

Another strong buying day ...no tick up yet anyone got Level 2

1 x 2.75 and 5 x 3.25
No change since the open

These things dont always follow logic . There was a 300,000 purchase at the full offer price of 3.25 but it didn't move the SP. At least momentum seems to be in the right direction so hopefully only a matter of time

BUY !!!!!

This going all the way back up...

Nar1-----Do you know of any reason for the rise today?
2517

Some Big buys been coming in over the past few days and more today.. Maybe this has been tipped or investers realising this is one of the few AIM stock making a profit

29 September 2009

Surgical Innovations Group plc

('SI' or 'the Group')

Interim Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, today reports its interim results for the six months ended 30 June 2009.




Highlights


Revenue increased by 14% to 1.99 million (2008: 1.74 million)


Operating profit increased by 185% to 234,000 (2008: 82,000)


Pre-tax profit increased by 95% to 215,000 (2008: 110,000)


Basic earnings per share of 0.05p (2008: 0.03p)


Secured a 90,000 government grant for capital investment


Launched the new LogiFlex product for obesity surgery in Europe


Improved trading with OEM partners

Entry into veterinary market


Surgical Innovations(TM) Group plc (AIM: SUN), the designer and manufacturer of
innovative surgical devices, is delighted to announce the success of its first
veterinary laparoscopic procedure, which was carried out by leading veterinary
surgeon Romain Pizzi for the first time on a reindeer at Edinburgh Zoo, using
the Group's specialist instrumentation.

Commenting on the surgery, Graham Bowland Managing Director of Surgical
Innovations Limited, said: "The veterinary market represents a significant
opportunity for SI. It is estimated that approximately one in two UK households
are pet owners. Veterinary surgeons perform an average of 600,000 open abdominal
procedures every year, but it is believed that only 1% of vets currently
practice laparoscopic surgery. We are working closely with the UK's leading vets
and organisations including the Royal Zoological Society of Scotland and Ark
Surgical, the UK's fastest growing veterinary distributor, to educate the
veterinary community of the benefits of laparoscopic surgery. By providing the
right instrumentation we hope to enable UK vets to introduce laparoscopic
techniques as part of their standard operating procedures."

Open abdominal surgery is currently the standard procedure in animals; however
there are a number of negative factors associated with it including more
post-operative pain, a higher risk of post-operative complications and
infections and a long recovery period. The minimally invasive nature of
laparoscopic surgery significantly reduces post-operative pain and the risk of
infection, which means the recovery period is faster and the animal requires
reduced post-operative care. For veterinary surgeons laparoscopic surgery offers
better visualisation of the operated area, allowing them to be more precise and
reach areas that are difficult to see in open surgery such as the liver and the
pelvic canal.

Sky News are going to show the reindeer in their next bulletin, due shortly.

A brief Sky News coverage!

That's almost worthy of a post on the Strange stories in the news thread :-)

At least nobody has to dig the reindeer up skinny!

SUN makes it into the Telegraph -

http://www.telegraph.co.uk/earth/wildlife/6807409/Reindeer-fit-for-Christmas-after-keyhole-surgery.html

Looks like entry into a new market...